Status:
COMPLETED
Study Watch Atrial Fibrillation (AF) Detection Investigation
Lead Sponsor:
Verily Life Sciences LLC
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective, non-randomized study to refine the Study Watch's algorithm for AF detection within both persistent and paroxysmal AF subjects. The study will also collect data from an FDA-clear...
Eligibility Criteria
Inclusion
- At least 18 years old
- Able to read and speak English
- Able and willing to sign written Informed Consent
- Interest in participating in the study
- Subjects with a known history of AF (including persistent or paroxysmal AF)
- Without significant limitation in ability to participate in the study, in the opinion of the investigator.
Exclusion
- Currently in a paced rhythm
- Known severe allergy to nickel or metal jewelry
- Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies
Key Trial Info
Start Date :
November 12 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 22 2019
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04074434
Start Date
November 12 2018
End Date
July 22 2019
Last Update
September 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Diego Cardiac Center
San Diego, California, United States, 92123